Metric Bio

Johnson & Johnson's have a definitive agreement to acquire V-Wave, a pioneering company dedicated to developing innovative treatment options for heart failure. This strategic acquisition will enhance Johnson & Johnson's position as a leader in cardiovascular care and accelerate their mission to address some of the most pressing global health challenges. V-Wave's cutting-edge Ventura® Interatrial Shunt technology targets heart failure with reduced ejection fraction (HFrEF), a condition affecting millions of patients worldwide. With the potential to be the first device of its kind to market, this minimally invasive implant could significantly improve patient outcomes and fill a critical treatment gap. This acquisition underscores Johnson & Johnson's commitment to expand into high-growth markets, deepening their relationships with heart failure specialists. Read more about this exciting milestone in transforming cardiovascular care below! https://lnkd.in/eVPgC_Zb #MetricBio #Recruitment #HealthcareInnovation #CardiovascularCare #HeartHealth #JohnsonAndJohnson 

Are you looking for a new challenge? At Metric Bio, we offer a wide range of positions available worldwide. Why not visit our jobs page today and see where your career change could take you?  https://lnkd.in/ePKhSeEP #MetricBio #Recruitment #NewRoles #WorldWide #CareerJourney  

Are you looking to relocate? We offer roles all around the world. In the CDMO and CRO industries, our most sought-after positions are in California where we offer a variety of opportunities. Why not visit our jobs page today and join many of our industry-leading partners in California?    Read below about some of our previous and current roles to see where your career journey could take you. https://lnkd.in/dSZ2fyyi #MetricBio #Recruitment #California #CDMO #CRO 

At Metric Bio, our talent acquisition specialists put your needs first, ensuring you have the best possible experience throughout your career journey. Our expert in the SaaS Health Tech and Life Sciences industries, and Business Development Lead, Caroline Graves, is dedicated to helping you get the most out of your career through fostering trusted relationships with her partners. Read below about Naif Zaman, Ph.D.’s experience with Caroline and visit her webpage to learn more. https://lnkd.in/enzPzyUC #MetricBio #Recruitment #CareerJourney #HealtTech #LifeScience 

Future Market Insights (FMI) has unveiled its latest industry analysis, revealing a promising trajectory for the global sterile injectable CDMO market. The market, valued at approximately $10.1 billion in 2023, is expected to soar to $33.7 billion by 2034 with a Compound Annual Growth Rate of 11.7%. This highlights the burgeoning opportunities within the sector. The industry is shifting towards an end-to-end business model, offering comprehensive services from API development to finished drug products. This change meets the rising demand for faster development and market readiness, especially in the biologics sector. Read more about this market surge below https://lnkd.in/eRsFkPHn #MetricBio #Recruitment #CDMO #MarketGrowth #Pharmaceuticals 

On the hunt for a new role? Check out our jobs page and connect with our world-class talent acquisition specialists. We're here to support you on your career journey and help you find the perfect opportunity. https://lnkd.in/ePKhSeEP #MetricBio #CurrentRole #NewRoles

At Metric Bio, we have some of the most highly sought after roles available for you to apply to.  Our Partners in the CRO and CDMO sectors are always on the lookout for Business Development professionals to play a key role in their companies’ growth.  Are you on the hunt for a Business Development role? Visit our jobs page and seize your next opportunity. https://lnkd.in/gb3zmmdJ #MetricBio #BusinessDevelopment #Currentroles #RecentPlacements

At Metric Bio, we're dedicated to delivering the best possible experience for our partners by building strong, personal relationships and deeply understanding your needs. James Barraclough, our Senior Group Manager and host of The MedTech Pulse podcast offers a highly personalized hiring process to help you accelerate your career journey. Check out Sandeepan Dutta, M.S.,M.B.A’s experience with James below, and visit his web page to learn more about his exceptional track record. https://lnkd.in/gvUSiq25 #MetricBio #CareerJourney #Partnerships #Commitment

Biological drugs derived from proteins, sugars, and cells are transforming medicine by treating autoimmune diseases, cancers, and more.    Yongchao Su, Senior Principal Scientist at Merck, is a leading figure in this field, applying his structural biophysics expertise to enhance biologic therapies. Su’s journey at Merck began over a decade ago, driven by a passion for understanding and improving these complex drugs. His work focuses on stabilizing and optimizing peptide and protein drugs, tackling challenges such as aggregation and formulation stability. Looking ahead, Su emphasizes the need for innovative approaches and interdisciplinary collaboration to address the evolving complexities of biologics. His team’s recent advancements, including novel NMR methods for analyzing lipid nanoparticles, highlight the importance of integrating fundamental science with practical drug development. Read below to explore the future of biologics and the impactful work being done in this dynamic field! https://lnkd.in/eBuJ6tXM #MetricBio #Biologics #PharmaceuticalScience #Innovation #StructuralBiophysics #Merck #DrugDevelopment 

New month, new opportunities!    Why not connect with one of our global talent acquisition specialists today and discover how we can help you discover an exciting new role?    Visit our jobs page and explore our website to learn more about our talented team. https://lnkd.in/ePKhSeEP #MetricBio #NewRoles #Opportunities #CurrentRoles